Healthy volunteers test new drug ABSK061 in Early-Stage safety trial
NCT ID NCT06306872
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This early-stage study tested the safety and how the body processes a new drug called ABSK061 in 40 healthy adults aged 18 to 45. Participants took the drug as minitablets, and researchers measured drug levels in the blood and monitored for side effects. The goal was to gather basic safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214062, China
Conditions
Explore the condition pages connected to this study.